HSPD1 and acute myeloid leukemia: One of the HSP60 missense variations shown in Table 1, Lysine-156, has been described before as modified by acetylation both in the human acute myeloid leukemia cell line MV4-11 (Choudhary et al., 2009) and in mouse liver HSP60 (Rardin et al., 2013).